These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31800621)

  • 1. Interactions of pharmaceutical companies with world countries, cancers and rare diseases from Wikipedia network analysis.
    Rollin G; Lages J; Serebriyskaya TS; Shepelyansky DL
    PLoS One; 2019; 14(12):e0225500. PubMed ID: 31800621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wikipedia network analysis of cancer interactions and world influence.
    Rollin G; Lages J; Shepelyansky DL
    PLoS One; 2019; 14(9):e0222508. PubMed ID: 31536541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collective intelligence defines biological functions in Wikipedia as communities in the hidden protein connection network.
    Zinovyev A; Czerwinska U; Cantini L; Barillot E; Frahm KM; Shepelyansky DL
    PLoS Comput Biol; 2020 Feb; 16(2):e1007652. PubMed ID: 32069277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capturing the influence of geopolitical ties from Wikipedia with reduced Google matrix.
    El Zant S; Jaffrès-Runser K; Shepelyansky DL
    PLoS One; 2018; 13(8):e0201397. PubMed ID: 30142201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highlighting entanglement of cultures via ranking of multilingual Wikipedia articles.
    Eom YH; Shepelyansky DL
    PLoS One; 2013; 8(10):e74554. PubMed ID: 24098338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of cultures and top people of Wikipedia from ranking of 24 language editions.
    Eom YH; Aragón P; Laniado D; Kaltenbrunner A; Vigna S; Shepelyansky DL
    PLoS One; 2015; 10(3):e0114825. PubMed ID: 25738291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J; DeAndrea DC
    J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategic imperatives for globalization of industries in developing countries: an Indian pharmaceutical industry example.
    Srivastava R; Chandra A; Kumar G
    Health Mark Q; 2004; 22(1):57-69. PubMed ID: 15914384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
    Liu BC; He L; He G; He Y
    J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccine THERATOPE- Biomira.
    Adis International Ltd
    Drugs R D; 2003; 4(4):236-40. PubMed ID: 12848588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. India's pharmaceutical industry: hype or high tech take-off?
    Malhotra P; Lofgren H
    Aust Health Rev; 2004 Nov; 28(2):182-93. PubMed ID: 15527398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Orphan drugs : New opportunities for the treatment of rare diseases].
    Beck M
    Internist (Berl); 2016 Nov; 57(11):1132-1138. PubMed ID: 27527064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Analysis for Chinese and US-listed Pharmaceutical Companies by the LightGBM Algorithm.
    Zheng W; Li J; Wang Y; Ye Z; Zhong H; Kot HW; Ouyang D; Chan G
    Curr Comput Aided Drug Des; 2023; 19(6):405-415. PubMed ID: 36703589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global marketing of cholesterol-lowering drugs as therapy.
    Elimimian JU; Gilmore JM; Singletary TJ
    J Hosp Mark Public Relations; 2006; 16(1-2):15-28. PubMed ID: 17194684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Companies look for profit in orphan drugs.
    Thompson CA
    Am J Health Syst Pharm; 2010 Nov; 67(22):1892, 1895-6. PubMed ID: 21048203
    [No Abstract]   [Full Text] [Related]  

  • 19. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study.
    Parker L; Fabbri A; Grundy Q; Mintzes B; Bero L
    BMJ; 2019 Dec; 367():l6694. PubMed ID: 31831471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products.
    Dear JW; Lilitkarntakul P; Webb DJ
    Br J Clin Pharmacol; 2006 Sep; 62(3):264-71. PubMed ID: 16934041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.